{"id":"W2907100365","doi":"10.1182/blood-2018-99-112067","title":"Nivolumab for Relapsed or Refractory Classical Hodgkin Lymphoma (cHL) after Autologous Hematopoietic Cell Transplantation (auto-HCT): Extended Follow-up of the Phase 2 Single-Arm CheckMate 205 Study","year":2018,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Cohort; Internal medicine; Nivolumab; Oncology; Clinical endpoint; Transplantation; Refractory (planetary science); Brentuximab vedotin; Phases of clinical research; Surgery; Lymphoma; Toxicity; Clinical trial; Cancer; Immunotherapy; Hodgkin lymphoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001864499,0.0004016458,0.00069141,0.0002034887,0.0002424521,0.0008403815,0.0004048769,0.0004050927,0.00126656],"category_scores_gemma":[0.0009494803,0.000217884,0.0009680584,0.0002882383,0.0002206495,0.0004661735,0.0003628136,0.0009218718,0.0002612411],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006704585,"about_ca_system_score_gemma":0.0005841338,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007087198,"about_ca_topic_score_gemma":0.002125639,"domain_scores_codex":[0.9996561,0.0001401038,0.00002562945,0.0000773535,0.0000464744,0.0000543062],"domain_scores_gemma":[0.9993425,0.00011149,0.0002099572,0.00009975903,0.00006003146,0.0001763156],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4495613,0.01215384,0.3126716,0.001882869,0.01270418,0.0005467072,0.0004463199,0.003094903,0.02935268,0.0005018454,0.008446514,0.1686373],"study_design_scores_gemma":[0.1187113,0.1648887,0.682288,0.0003618808,0.01025801,0.001204815,0.0002337958,0.003270059,0.005663803,0.0005525828,0.01247461,0.00009255543],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9951755,0.002068846,0.0002190774,0.00008977893,0.00003111744,0.0003294708,0.001367096,0.00001910042,0.0007001014],"genre_scores_gemma":[0.9951687,0.0006188138,0.0003348718,0.0003272812,0.00005747664,0.0002511818,0.002773733,0.000006719146,0.0004613771],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001864499,"threshold_uncertainty_score":0.009860516,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02067717367996881,"score_gpt":0.281082601874021,"score_spread":0.2604054281940522,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}